Objectives: Atopic dermatitis, also known as atopic eczema, is a chronic inflammatory skin disease. The main objective of this study is to document atopic dermatitis patients clinical-epidemiological profiles and therapeutic approaches.
Methods: The study is a retrospective cross-sectional study conducted at King Abdulaziz Medical City, Jeddah, Saudi Arabia, including records from 2016 to 2020.
Results: Of the total 125 patients, 65 (52%) were males and 60 (48%) were females. Almost half (53%) of the study subjects reported a positive family history of at least one of the atopic triad diseases. 44 (35%) patients have another atopic disease, with bronchial asthma being the most common associated atopy. Multiple sites were affected in 63% of the patients, followed by the upper extremities (17.6%), lower extremities (11.2%), and finally the face (6.4%). Almost all patients (91%) received emollients and moisturizers as therapy. Topical steroids were the second most common treatment choice (82%). Most of the patients did not report aggravating factors, of those who reported, weather changes were the most common aggravating factor (12%).
Conclusion: The clinical-epidemiological features of atopic dermatitis patients are consistent with global reports except for the affected sites, affected age group, and finally aggravating factors. This calls for the conduction of further studies in various centres across the Kingdom to provide more representative data on atopic dermatitis patients characteristics.
Key words: Atopic dermatitis, Eczema, Clinical profiles, Medications
|
